Cardiol Therapeutics (CRDL) Profit After Tax (2020 - 2026)
Cardiol Therapeutics (CRDL) posted Profit After Tax of -$7.9 million for Q1 2026, down 52.53% on a QoQ basis from -$5.2 million in Q4 2025, and down 236.59% year-over-year from $5.8 million in Q1 2025.
Cardiol Therapeutics (CRDL) Profit After Tax (2020 - 2026) Analysis & Trends
Cardiol Therapeutics' Profit After Tax history runs 7 years deep, the most recent figure standing at -$7.9 million for Q1 2026.
- Quarterly Profit After Tax fell 236.59% year-over-year to -$7.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.9 million (down 184.22% YoY) and the FY2025 annual result came in at -$24.3 million, up 7.63% from the prior year.
- Profit After Tax was -$7.9 million for Q1 2026 at Cardiol Therapeutics, down from -$5.2 million in the prior quarter.
- Across five years, Profit After Tax topped out at $9.3 million in Q3 2024 and bottomed at -$40.0 million in Q4 2022.
- A 5-year average of -$3.7 million and a median of -$5.2 million in 2025 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax plunged 706.5% — and 2024, when it jumped 310.93%.
- Cardiol Therapeutics' Profit After Tax stood at -$40.0 million in 2022, then surged by 85.99% to -$5.6 million in 2023, then decreased by 4.36% to -$5.9 million in 2024, then gained by 11.66% to -$5.2 million in 2025, then tumbled by 52.53% to -$7.9 million in 2026.
- Business Quant data shows CRDL's Profit After Tax at -$7.9 million in Q1 2026, -$5.2 million in Q4 2025, and $7.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Cardiol Therapeutics | 134.05 Mn | 134.05 Mn | - | -7.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.89 Mn |
| Dec 31, 2025 | -5.17 Mn |
| Sep 30, 2025 | 7.24 Mn |
| Jun 30, 2025 | -6.03 Mn |
| Mar 31, 2025 | 5.78 Mn |
| Dec 31, 2024 | -5.85 Mn |
| Sep 30, 2024 | 9.33 Mn |
| Jun 30, 2024 | 4.82 Mn |
| Mar 31, 2024 | -6.81 Mn |
| Dec 31, 2023 | -5.61 Mn |
| Sep 30, 2023 | -4.42 Mn |
| Jun 30, 2023 | 5.56 Mn |
| Mar 31, 2023 | 5.24 Mn |
| Dec 31, 2022 | -40.04 Mn |
| Sep 30, 2022 | -6.11 Mn |
| Jun 30, 2022 | -5.09 Mn |
| Mar 31, 2022 | -7.07 Mn |
| Dec 31, 2021 | -4.96 Mn |
| Sep 30, 2021 | 7.87 Mn |
| Jun 30, 2021 | -5.34 Mn |